{"name":"Beersheva Mental Health Center","slug":"beersheva-mental-health-center","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"testosterone gel (Androgel)","genericName":"testosterone gel (Androgel)","slug":"testosterone-gel-androgel","indication":"Testosterone replacement therapy in adult males with hypogonadism","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Amisulpride, Moclobemide","genericName":"Amisulpride, Moclobemide","slug":"amisulpride-moclobemide","indication":"Schizophrenia with depressive symptoms","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Bexarotene (Targretin LGD1069)","genericName":"Bexarotene (Targretin LGD1069)","slug":"bexarotene-targretin-lgd1069","indication":"Cutaneous T-cell lymphoma (mycosis fungoides)","status":"phase_3"}]}],"pipeline":[{"name":"testosterone gel (Androgel)","genericName":"testosterone gel (Androgel)","slug":"testosterone-gel-androgel","phase":"marketed","mechanism":"Testosterone gel replaces deficient endogenous testosterone by transdermal absorption to restore normal androgen levels.","indications":["Testosterone replacement therapy in adult males with hypogonadism"],"catalyst":""},{"name":"Amisulpride, Moclobemide","genericName":"Amisulpride, Moclobemide","slug":"amisulpride-moclobemide","phase":"phase_3","mechanism":"This combination uses amisulpride (a dopamine D2/D3 antagonist) and moclobemide (a reversible monoamine oxidase-A inhibitor) to modulate dopaminergic and monoaminergic neurotransmission for psychiatric symptom management.","indications":["Schizophrenia with depressive symptoms","Schizoaffective disorder"],"catalyst":""},{"name":"Bexarotene (Targretin LGD1069)","genericName":"Bexarotene (Targretin LGD1069)","slug":"bexarotene-targretin-lgd1069","phase":"phase_3","mechanism":"Bexarotene is a retinoid X receptor (RXR) agonist that selectively activates RXR to promote differentiation and apoptosis of malignant T cells.","indications":["Cutaneous T-cell lymphoma (mycosis fungoides)","Cutaneous manifestations of cutaneous T-cell lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":1,"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}